| Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
| Tel: |
15076683720 |
| Email: |
klq@cw-bio.com |
| Products Intro: |
Product Name:MRZ2-514
CAS:202808-11-5
Purity:≥98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
|
| | MRZ 2-514 Basic information |
| Product Name: | MRZ 2-514 | | Synonyms: | MRZ 2-514;8-bromo-4;5-dihydroxypyridazino[4;5-b]quinolin-1-one;Pyridazino[4,5-b]quinoline-1,4-dione, 8-bromo-2,3-dihydro-, 5-oxide;8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one;inhibit,Inhibitor,MRZ 2514,MRZ 2 514,MRZ 2-514,iGluR,Ionotropic glutamate receptors;8-Bromo-1,4-dioxo-1,2,3,4-tetrahydropyridazino[4,5-b]quinoline 5-oxide | | CAS: | 202808-11-5 | | MF: | C11H6BrN3O3 | | MW: | 308.09 | | EINECS: | | | Product Categories: | | | Mol File: | 202808-11-5.mol |  |
| | MRZ 2-514 Chemical Properties |
| density | 2.07±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | pka | 9.37±0.20(Predicted) | | color | Yellow to orange |
| | MRZ 2-514 Usage And Synthesis |
| Biological Activity | MRZ 2-514 is an NMDA receptor (glycineB) antagonist with a Ki of 33 μM. | | in vitro | MRZ 2-514 has IC 50 values against peak AMPA-induced currents of 72.7 μM. < /div> | | in vivo | MRZ 2/514 has anticonvulsive action in the MES model in mice, and the effect is prolonged by probenecid. | | target | |
| | MRZ 2-514 Preparation Products And Raw materials |
|